| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.07B | $2.04B | $2.06B |
| YoY Revenue Growth % | +1.6% | -0.8% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $845.6M | $603.7M | $794.0M |
| Operating Margin % | 40.8% | 29.6% | 38.6% |
| Net Income (GAAP) | $716.6M | $511.6M | $672.9M |
| EBITDA (Normalized) | $850.5M | $606.4M | $868.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $973.2M | $932.1M | $874.3M |
| Capital Expenditures (CapEx) | $6.1M | $3.4M | $92.6M |
| Free Cash Flow (FCF) | $967.1M | $928.7M | $781.7M |
| FCF Margin % | 46.6% | 45.5% | 38.0% |
| Return on Invested Capital (ROIC %) | 13.9% | 11.1% | 18.3% |
| Cash & Short-Term Equivalents | $586.0M | $950.0M | — |
| Total Debt (Short + Long Term) | $2.15B | $1.88B | $1.33B |
| Total Stockholders' Equity | $3.24B | $3.35B | $2.72B |